Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Niraparib in Combination With EGFR Inhibitor Panitumumab in Patients With Advanced Colorectal Cancer

NCT03983993 is registered in ClinicalTrials.gov with Emory University as lead sponsor.

NCT NCT03983993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03983993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Niraparib in Combination With EGFR Inhibitor Panitumumab in Patients With Advanced Colorectal Cancer
Lead sponsor
Emory University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
October 15, 2019
Completion date
December 1, 2026
Enrollment
26 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

advanced microsatellite stable colorectal carcinoma, metastatic microsatellite stable colorectal carcinoma, microsatellite stable, msi-h colorectal cancer, ras wild type, stage iv colorectal cancer ajcc v8